Express Scripts Holding Company Company Profile (NASDAQ:ESRX)

About Express Scripts Holding Company (NASDAQ:ESRX)

Express Scripts Holding Company logoExpress Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Health Care Services
  • Symbol: NASDAQ:ESRX
  • CUSIP: 30219G10
  • Web: www.express-scripts.com
Capitalization:
  • Market Cap: $35.66 billion
  • Outstanding Shares: 593,526,000
Average Prices:
  • 50 Day Moving Avg: $63.09
  • 200 Day Moving Avg: $68.54
  • 52 Week Range: $57.80 - $80.02
P/E:
  • Trailing P/E Ratio: 10.89
  • Foreward P/E Ratio: 7.80
  • P/E Growth: 0.72
Sales & Book Value:
  • Annual Revenue: $100.15 billion
  • Price / Sales: 0.36
  • Book Value: $26.83 per share
  • Price / Book: 2.24
Profitability:
  • EBIDTA: $7.14 billion
  • Net Margins: 2.70%
  • Return on Equity: 24.99%
  • Return on Assets: 7.67%
Debt:
  • Debt-to-Equity Ratio: 0.96%
  • Current Ratio: 0.70%
  • Quick Ratio: 0.59%
Misc:
  • Average Volume: 5.22 million shs.
  • Beta: 0.92
  • Short Ratio: 6.67
 

Frequently Asked Questions for Express Scripts Holding Company (NASDAQ:ESRX)

What is Express Scripts Holding Company's stock symbol?

Express Scripts Holding Company trades on the NASDAQ under the ticker symbol "ESRX."

How were Express Scripts Holding Company's earnings last quarter?

Express Scripts Holding Company (NASDAQ:ESRX) announced its earnings results on Monday, April, 24th. The company reported $1.33 earnings per share for the quarter, beating analysts' consensus estimates of $1.32 by $0.01. The firm had revenue of $24.65 billion for the quarter, compared to analyst estimates of $24.95 billion. Express Scripts Holding Company had a net margin of 2.70% and a return on equity of 24.99%. The company's revenue for the quarter was down .6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.22 EPS. View Express Scripts Holding Company's Earnings History.

When will Express Scripts Holding Company make its next earnings announcement?

Express Scripts Holding Company is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for Express Scripts Holding Company.

What guidance has Express Scripts Holding Company issued on next quarter's earnings?

Express Scripts Holding Company updated its FY17 earnings guidance on Monday, April, 24th. The company provided EPS guidance of $6.90-7.04 for the period, compared to the Thomson Reuters consensus estimate of $6.93. Express Scripts Holding Company also updated its Q2 guidance to $1.70-1.74 EPS.

Where is Express Scripts Holding Company's stock going? Where will Express Scripts Holding Company's stock price be in 2017?

18 brokers have issued 12 month target prices for Express Scripts Holding Company's stock. Their forecasts range from $52.00 to $88.00. On average, they expect Express Scripts Holding Company's stock price to reach $70.75 in the next year. View Analyst Ratings for Express Scripts Holding Company.

What are analysts saying about Express Scripts Holding Company stock?

Here are some recent quotes from research analysts about Express Scripts Holding Company stock:

  • 1. Jefferies Group LLC analysts commented, "We believe ESRX remains a Buy given our view that company fundamentals, including its FCF, are stable and that the stock's valuation is attractive at 9x FY18 P/E. That said, we recognize that headlines surrounding drug pricing pressure and the overhang from ESRX's Anthem contract will drive continued stock volatility NT." (2/17/2017)
  • 2. According to Zacks Investment Research, "Express Scripts’ fourth-quarter 2016 results were mixed, wherein adjusted earnings topped the Zacks Consensus Estimate, revenues beat the same. In the past three months, the company has underperformed the broader industry with respect to price performance. While the company’s guidance for 2017 was encouraging, tough competition in the Pharmacy Benefit Management space and the persistent drug pricing issue are expected to affect the share price. Express Scripts stands to benefit from increased generic utilization, shift toward mail orders, strong specialty growth and an aging population. The company is focused on the development of both specialty drugs and generics, which are expected to account for 50% of the total drug expenditure by 2018. Further, its SafeGuardRx suite of products is designed to better manage specialty spend in turn, establishing a higher standard for patient outcomes." (2/16/2017)
  • 3. Credit Suisse Group AG analysts commented, "We continue to believe ESRX will seek to buy Rite Aid’s PBM unit from Walgreens if the deal closes successfully and possibly add its generic purchasing clout to Walgreen’s buying consortium for added economics. Derivatives: At a time when hapless politicians are wringing their wrists about out of control drug costs, we cite another example of a large government payor tapping PBM solutions for greater savings. As opposed to Anthem, TRICARE utilizes a number of ESRX’s cost management tools in addition to a preferred pharmacy network to better manage its trend. We see the PBM model as more rather than less relevant to the current situation, and we see longer-term enhanced roles for PBMs in Medicare part D and B. Separately, we see AmerisourceBergen as benefiting from the news as Walgreen’s supplier, while Cardinal Health stand to lose some share as CVS’s partner." (10/3/2016)

Are investors shorting Express Scripts Holding Company?

Express Scripts Holding Company saw a increase in short interest in May. As of May 15th, there was short interest totalling 34,835,030 shares, an increase of 4.3% from the April 28th total of 33,395,406 shares. Based on an average trading volume of 4,533,623 shares, the short-interest ratio is currently 7.7 days. Approximately 5.9% of the shares of the stock are short sold.

Who are some of Express Scripts Holding Company's key competitors?

Who owns Express Scripts Holding Company stock?

Express Scripts Holding Company's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.78%), State Street Corp (4.56%), Barrow Hanley Mewhinney & Strauss LLC (2.97%), Bank of New York Mellon Corp (1.85%), Macquarie Group Ltd. (1.85%) and Veritas Asset Management LLP (1.22%). Company insiders that own Express Scripts Holding Company stock include Christopher A Mcginnis, Everett Neville, Gary Wimberly, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr. View Institutional Ownership Trends for Express Scripts Holding Company.

Who sold Express Scripts Holding Company stock? Who is selling Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Wedgewood Partners Inc., Brave Warrior Advisors LLC, Manning & Napier Advisors LLC, Schroder Investment Management Group, Teachers Advisors LLC, FIL Ltd and Glen Harbor Capital Management LLC. Company insiders that have sold Express Scripts Holding Company stock in the last year include Christopher A Mcginnis, Everett Neville, Phyllis S Anderson and Woodrow A Myers Jr. View Insider Buying and Selling for Express Scripts Holding Company.

Who bought Express Scripts Holding Company stock? Who is buying Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was bought by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., Renaissance Technologies LLC, Baupost Group LLC MA, Ameriprise Financial Inc., Barrow Hanley Mewhinney & Strauss LLC, Vanguard Group Inc., Artisan Partners Limited Partnership and UBS Asset Management Americas Inc.. View Insider Buying and Selling for Express Scripts Holding Company.

How do I buy Express Scripts Holding Company stock?

Shares of Express Scripts Holding Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Express Scripts Holding Company stock cost?

One share of Express Scripts Holding Company stock can currently be purchased for approximately $60.09.

Analyst Ratings

Consensus Ratings for Express Scripts Holding Company (NASDAQ:ESRX) (?)
Ratings Breakdown: 3 Sell Ratings, 10 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.11)
Consensus Price Target: $70.75 (17.74% upside)

Analysts' Ratings History for Express Scripts Holding Company (NASDAQ:ESRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/26/2017Evercore ISILower Price TargetIn-Line$68.50 -> $59.00MediumView Rating Details
4/26/2017Morgan StanleyLower Price TargetUnderweight$71.00 -> $52.00MediumView Rating Details
4/26/2017Edward JonesDowngradeBuy -> HoldHighView Rating Details
4/25/2017Robert W. BairdLower Price TargetNeutral$73.00 -> $53.00HighView Rating Details
4/25/2017SunTrust Banks, Inc.Reiterated RatingBuyHighView Rating Details
4/25/2017Cowen and CompanyLower Price TargetOutperform$90.00 -> $83.00HighView Rating Details
4/25/2017Bank of America CorpReiterated RatingNeutral$77.00HighView Rating Details
4/25/2017MizuhoLower Price TargetNeutral -> Neutral$76.00 -> $61.00HighView Rating Details
4/20/2017Jefferies Group LLCSet Price TargetBuy$88.00LowView Rating Details
3/29/2017ArgusReiterated RatingHoldLowView Rating Details
3/15/2017Wells Fargo & CoDowngradeMarket Perform -> UnderperformLowView Rating Details
3/8/2017Leerink SwannReiterated RatingMarket Perform$75.00LowView Rating Details
2/16/2017Credit Suisse Group AGReiterated RatingBuy$85.00N/AView Rating Details
2/14/2017Oppenheimer Holdings Inc.Reiterated RatingHoldN/AView Rating Details
12/16/2016Barclays PLCReiterated RatingOverweightN/AView Rating Details
12/1/2016Sanford C. BernsteinReiterated RatingUnderperform$59.00N/AView Rating Details
11/3/2016Deutsche Bank AGUpgradeSell -> Hold$69.00 -> $70.00N/AView Rating Details
6/1/2016WedbushReiterated RatingNeutralN/AView Rating Details
5/24/2016Citigroup IncReiterated RatingBuyN/AView Rating Details
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00N/AView Rating Details
3/18/2016William BlairReiterated RatingBuyN/AView Rating Details
2/18/2016Goldman Sachs Group IncLower Price TargetNeutral$82.00 -> $74.00N/AView Rating Details
2/17/2016Maxim GroupReiterated RatingBuy$109.00 -> $95.00N/AView Rating Details
12/23/2015BMO Capital MarketsBoost Price TargetMarket Perform$94.00N/AView Rating Details
11/29/2015JPMorgan Chase & Co.Reiterated RatingBuy$105.00N/AView Rating Details
7/30/2015Royal Bank of CanadaBoost Price TargetOutperform$87.00 -> $96.00N/AView Rating Details
6/18/2015StephensInitiated CoverageMarket PerformN/AView Rating Details
6/1/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 5/25/2015 forward)

Earnings

Earnings History for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Earnings History by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2017        
4/24/2017Q1 17$1.32$1.33$24.95 billion$24.65 billionViewN/AView Earnings Details
2/14/2017Q4 2016$1.87$1.88$26.31 billion$24.90 billionViewListenView Earnings Details
10/25/2016Q3$1.74$1.74$25.48 billion$25.41 billionViewListenView Earnings Details
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details
7/28/2015Q215$1.40$1.44$26.13 billion$25.45 billionViewListenView Earnings Details
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details
7/29/2014Q214$1.22$1.23$24.42 billion$25.11 billionViewListenView Earnings Details
4/29/2014Q114$1.01$0.99$23.81 billion$23.69 billionViewListenView Earnings Details
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details
10/25/2013Q313$1.08$1.08$25.01 billion$25.92 billionViewListenView Earnings Details
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.06 billionViewListenView Earnings Details
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details
8/7/2012$0.82$0.88ViewN/AView Earnings Details
5/10/2012$0.77$0.73ViewN/AView Earnings Details
2/22/2012$0.85$0.82ViewN/AView Earnings Details
10/25/2011$0.77$0.79ViewN/AView Earnings Details
7/21/2011$0.69$0.71ViewN/AView Earnings Details
4/26/2011$0.69$0.66ViewN/AView Earnings Details
2/16/2011$0.70$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)
2017 EPS Consensus Estimate: $6.95
2018 EPS Consensus Estimate: $7.60
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$1.31$1.33$1.32
Q2 20175$1.68$1.72$1.70
Q3 20175$1.86$1.90$1.88
Q4 20175$2.02$2.06$2.04
Q1 20183$1.45$1.49$1.47
Q2 20183$1.85$1.91$1.87
Q3 20183$2.02$2.10$2.05
Q4 20183$2.16$2.26$2.21
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Express Scripts Holding Company (NASDAQ:ESRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Ownership Percentage: 0.54%
Institutional Ownership Percentage: 85.36%
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Trades by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2017Phyllis S AndersonVPSell1,100$60.08$66,088.00View SEC Filing  
3/1/2017Everett NevilleSVPSell2,352$70.16$165,016.32View SEC Filing  
1/3/2017Everett NevilleVPSell1,123$69.41$77,947.43View SEC Filing  
9/14/2016Woodrow A Myers JrDirectorSell12,036$70.40$847,334.40View SEC Filing  
9/12/2016Christopher A McginnisVPSell1,785$70.77$126,324.45View SEC Filing  
5/10/2016Everett NevilleVPSell800$74.11$59,288.00View SEC Filing  
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.26View SEC Filing  
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.24View SEC Filing  
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.96View SEC Filing  
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.00View SEC Filing  
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.49View SEC Filing  
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.00View SEC Filing  
3/10/2014Steven MillerVPSell12,664$77.96$987,285.44View SEC Filing  
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.43View SEC Filing  
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.00View SEC Filing  
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.00View SEC Filing  
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.20View SEC Filing  
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.48View SEC Filing  
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Express Scripts Holding Company (NASDAQ:ESRX)
Latest Headlines for Express Scripts Holding Company (NASDAQ:ESRX)
Source:
DateHeadline
americanbankingnews.com logoInsider Selling: Express Scripts Holding Company (ESRX) VP Sells 1,100 Shares of Stock
www.americanbankingnews.com - May 23 at 10:36 PM
finance.yahoo.com logoAmazon's Next Big Thing Should Make Pharmacies Very Scared
finance.yahoo.com - May 22 at 11:42 AM
americanbankingnews.com logoExpress Scripts Holding Company to Post FY2017 Earnings of $6.98 Per Share, William Blair Forecasts (ESRX)
www.americanbankingnews.com - May 22 at 7:22 AM
bizjournals.com logoExpress Scripts' executive compensation, stock ownership and more
www.bizjournals.com - May 19 at 5:19 AM
finance.yahoo.com logoWhy Chanos Is Shorting Mallinckrodt and Express Scripts
finance.yahoo.com - May 19 at 5:19 AM
finance.yahoo.com logoChanos on Mallinckrodt, Express Scripts, Tesla and China
finance.yahoo.com - May 19 at 5:19 AM
finance.yahoo.com logoEvaluating Amazon's Chances in the Pharma Industry
finance.yahoo.com - May 19 at 5:19 AM
finance.yahoo.com logoExpress Scripts Subsidiary to Join Walgreens Boots Alliance Development Group Purchasing Organization
finance.yahoo.com - May 18 at 10:23 AM
finance.yahoo.com logoExpress Scripts targets workers’ comp market with myMatrixx buy
finance.yahoo.com - May 17 at 10:03 PM
finance.yahoo.com logoExpress Scripts and myMatrixx Combine To Offer Best-in-Class Pharmacy Services for Workers' Compensation Programs
finance.yahoo.com - May 17 at 5:02 PM
finance.yahoo.com logoCVS shares slip after report Amazon's getting into pharmacy
finance.yahoo.com - May 17 at 10:52 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 15 at 12:02 PM
seekingalpha.com logoExpress Scripts Growth Appeals To Billionaire Klarman's Margin Of Safety Criteria
seekingalpha.com - May 14 at 9:10 AM
prnewswire.com logoExpress Scripts Holding Company to Present at an Upcoming Conference - PR Newswire (press release)
www.prnewswire.com - May 9 at 8:31 AM
finance.yahoo.com logoExpress Scripts Holding Company to Present at an Upcoming Conference
finance.yahoo.com - May 9 at 8:31 AM
americanbankingnews.com logoZacks: Brokerages Anticipate Express Scripts Holding Company (ESRX) Will Announce Earnings of $1.71 Per Share
www.americanbankingnews.com - May 8 at 11:54 PM
americanbankingnews.com logo$25.33 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter
www.americanbankingnews.com - May 8 at 11:54 PM
finance.yahoo.com logoExpress Scripts launches drug discount subsidiary
finance.yahoo.com - May 8 at 4:53 PM
finance.yahoo.com logoDebate Intensifies Over Express Scripts Future As Standalone PBM
finance.yahoo.com - May 8 at 9:08 AM
finance.yahoo.com logoCross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs
finance.yahoo.com - May 8 at 9:08 AM
finance.yahoo.com logo[$$] Pricing row shines spotlight on US pharmacy benefit managers
finance.yahoo.com - May 7 at 10:26 AM
finance.yahoo.com logoExpress Scripts Recognized Among Most Diverse U.S. Companies by DiversityInc
finance.yahoo.com - May 5 at 5:16 PM
finance.yahoo.com logo6 Stocks Young Warren Buffett Would Buy in 2017
finance.yahoo.com - May 5 at 5:16 PM
americanbankingnews.com logo Analysts Anticipate Express Scripts Holding Company (ESRX) Will Post Quarterly Sales of $25.33 Billion
www.americanbankingnews.com - May 5 at 12:06 PM
finance.yahoo.com logoInside the ‘Scorpion Room’ Where Drug Price Secrets Are Guarded
finance.yahoo.com - May 4 at 11:55 AM
americanbankingnews.com logo Brokerages Anticipate Express Scripts Holding Company (ESRX) to Post $1.71 Earnings Per Share
www.americanbankingnews.com - May 4 at 1:37 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Earns Daily News Sentiment Rating of 0.11
www.americanbankingnews.com - May 3 at 11:46 PM
forbes.com logoYacktman Buys Troubled Express Scripts, Sells S&P 500
www.forbes.com - May 3 at 9:55 PM
finance.yahoo.com logoAs Insurers Shuffle PBMs, Aetna Looks At Closer Ties To CVS
finance.yahoo.com - May 3 at 8:08 AM
streetinsider.com logoAmerisourceBergen (ABC) Enters New Five-Year Pharmaceutical Supply Agreement with Express Scripts (ESRX)
www.streetinsider.com - May 1 at 4:53 PM
streetinsider.com logoAmerisourceBergen (ABC) Enters New Five-Year Pharmaceutical Supply Agreement with Express Scripts (ESRX) - StreetInsider.com
www.streetinsider.com - May 1 at 8:20 AM
americanbankingnews.com logoMorgan Stanley Trims Express Scripts Holding Company (ESRX) Target Price to $52.00
www.americanbankingnews.com - May 1 at 12:14 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Getting Somewhat Favorable Press Coverage, Study Shows
www.americanbankingnews.com - April 30 at 4:55 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Express Scripts Holding ... - Yahoo Finance
finance.yahoo.com - April 29 at 5:41 PM
americanbankingnews.com logoEquities Analysts Offer Predictions for Express Scripts Holding Company's Q4 2017 Earnings (ESRX)
www.americanbankingnews.com - April 28 at 8:38 PM
americanbankingnews.com logoWilliam Blair Comments on Express Scripts Holding Company's Q2 2017 Earnings (ESRX)
www.americanbankingnews.com - April 28 at 10:14 AM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Earning Somewhat Favorable Press Coverage, Report Finds
www.americanbankingnews.com - April 27 at 6:52 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Express Scripts Holding Company (ESRX)
finance.yahoo.com - April 27 at 5:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Express Scripts Holding Company
finance.yahoo.com - April 27 at 5:36 PM
americanbankingnews.com logoExpress Scripts Holding Company (ESRX) Expected to Post FY2017 Earnings of $6.97 Per Share
www.americanbankingnews.com - April 27 at 1:36 PM
americanbankingnews.com logoJefferies Group Brokers Lift Earnings Estimates for Express Scripts Holding Company (ESRX)
www.americanbankingnews.com - April 27 at 9:18 AM
americanbankingnews.com logoEquities Analysts Set Expectations for Express Scripts Holding Company's Q2 2017 Earnings (ESRX)
www.americanbankingnews.com - April 27 at 9:18 AM
americanbankingnews.com logoBrokers Set Expectations for Express Scripts Holding Company's Q2 2017 Earnings (ESRX)
www.americanbankingnews.com - April 27 at 9:18 AM
seekingalpha.com logoExpress Scripts Holding (ESRX) Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - April 26 at 10:38 PM
finance.yahoo.com logo[$$] Express Scripts Stock Seen Reaching $88
finance.yahoo.com - April 26 at 10:38 PM
finance.yahoo.com logoA Secret Profit Formula Loved by Drug Middlemen Is at Risk
finance.yahoo.com - April 26 at 10:38 PM
finance.yahoo.com logoExpress Scripts Whipsaws Amid Public Soap Opera With Anthem
finance.yahoo.com - April 26 at 10:38 PM
finance.yahoo.com logoAnthem says it hasn't ruled out any PBM, including Express Scripts
finance.yahoo.com - April 26 at 10:38 PM
finance.yahoo.com logoExpress Scripts stock surges 3% after Anthem says no final decision made about 2020 contract
finance.yahoo.com - April 26 at 10:38 PM
finance.yahoo.com logoExpress Scripts stock surges on investor hopes for an Anthem reconciliation
finance.yahoo.com - April 26 at 10:38 PM

Social

Chart

Express Scripts Holding Company (ESRX) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by MarketBeat.com Staff